Conclusion: Effective policy and interventions have resulted in decreased proportions of women diagnosed with metastatic breast cancer at diagnosis in high-income countries, yet inequality persists, which needs to be addressed through increased awareness of breast cancer symptoms and early detection. Improving global coverage and quality of population-based cancer registries, including the collection of standardized stage data, is key to monitoring progress.
PubMed 37943547 ↗Daa
The short answer. There isn't much data on Daa yet — 24 mentions, 7 with a clear outcome — so treat these numbers as anecdotal. It is most often used for hormones: 100% of 6 reports say that improved. It is well studied — 190 meta-analyses on PubMed.
From 24 mentions in total — the rest didn't say how it went and aren't counted.
What Daa does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 190 meta-analyses on PubMed ↗ · 137 randomized trials ↗
Conclusion: The DAA has better early functional outcomes with shorter mean length of stay but was associated with a longer operative time than PA. There was no difference in risk of dislocations, neurapraxias, periprosthetic fractures or VTE between approaches. Based on our results, choice of THA approach should ultimately be guided by surgeon experience, surgeon preference and patient factors.
PubMed 37010580 ↗Conclusion: In this study, moderate to high certainty evidence indicated that compared with PA, all surgical approaches except DLA were associated with similar improvements of hip score but longer operation time. DLA was associated with smaller improvement of hip score. The safety of the different approaches did not show significant differences. These findings will help health professionals and patients with better clinical decision-making and also provide references for policy makers.
PubMed 36719679 ↗Conclusion: Daclatasvir plus PR was the most effective in SVR12 and SVR24, but caused an increased AEs profile (headache and insomnia). Combined ledipasvir with sofosbuvir or combination of PR was associated with higher incidence of fatigue and nausea.
PubMed 26945424 ↗163 human trials on ClinicalTrials.gov test Daa — 95 completed, 9 recruiting now. See all on ClinicalTrials.gov ↗
- Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease · Heptatitis C · 2024
- Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir · Hepatitis C · 2017
- The Kentucky Viral Hepatitis Treatment Study · Hepatitis C, Opioid-Related Disorders · 2025
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“ZMA and nofap are decent and prob my fav also along with DAA and transresveratrol”
“there are studies that show that DAA actually does help, and i would rather use this instead of actual SERMs if it helps”
“I take about 3.5 g (half tbsp) a day...I have noticed a good change with it and I'm a big fan”
“DAA if that. I ran 20mg a day for 8 weeks and had minor suppression. test level jumped back up to normal 3-4 weeks after the end of the cycle.”
Other options for hormones
Sources
- User reports: 24 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate